Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Capecitabine in malignant mesothelioma: a phase II trial by the Cancer and Leukemia Group B (39807).
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Capecitabine in malignant mesothelioma: a phase II trial by the Cancer and Leukemia Group B (39807).
Capecitabine in malignant mesothelioma: a phase II trial by the Cancer and Leukemia Group B (39807). Lung Cancer. 2004 May; 44(2):251-9.
View in:
PubMed
subject areas
Administration, Oral
Adult
Aged
Aged, 80 and over
Antimetabolites, Antineoplastic
Capecitabine
Deoxycytidine
Disease-Free Survival
Female
Fluorouracil
Humans
Male
Mesothelioma
Middle Aged
Pleural Neoplasms
Treatment Outcome
authors with profiles
Hedy Kindler